From: A competing risk analysis of colorectal cancer recurrence after curative surgery
Variable | Groups compared | Gray test p value |
---|---|---|
Age (years) | < 60 vs 60–74 | 0.858 |
< 60 vs ≥ 75 | 0.344 | |
60–74 vs ≥ 75 | 0.463 | |
Sex | Male vs female | 0.247 |
Tumour location | Colon vs sigmoid/rectosigmoid | 0.199 |
Colon vs rectum | 0.796 | |
Sigmoid/rectosigmoid vs rectum | 0.142 | |
Tumor type | Adenocarcinoma vs mucinous | 0.118 |
Histological grade | Low/well differentiated vs moderate | 0.477 |
Low/well differentiated vs high/poorly differentiated | 0.933 | |
Moderate vs high/poorly differentiated | 0.793 | |
T stage (depth) | T1/ T2 vs T3 | 0.038 |
T1/ T2 vs T4 | < 0.001 | |
T3 vs T4 | < 0.001 | |
N stage (nodes) | N0 vs N1 | 0.119 |
N0 vs N2 | < 0.001 | |
N1 vs N2 | < 0.001 | |
Vascular invasion | Absent vs present/suspicious | < 0.001 |
Perineural invasion | Absent vs present | 0.076 |
Positive margins | Uninvolved vs positive margin | 0.001 |
Nodes examined | < 12 vs ≥ 12 | 0.852 |
Post-operative adjuvant therapy | None vs chemotherapy and/or radiation | < 0.001 |